ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
A Biomimetic Lubricant Captures Hyaluronic Acid In Situ to Regenerate Cartilage: From Bench to Bedside.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Proteoglycan-Mimetic Bottle-Brush Polymer Brushes for Osteoarthritis Therapy: Lubrication Enhancement and Multifunctional Disease Modulation.Macromolecular rapid communications · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Lubrication deficiency can lead to cartilage degeneration and osteoarthritis (OA), for which hyaluronic acid (HA) is limited by its short retention and reparative effect. Inspired by the natural cartilage lubrication mechanism, we propose a two-step injection strategy to construct a biomimetic synergistic lubrication coating in situ on cartilage surfaces. The administration of developed cationic biomimetic lubricant (CS-g-PM) as the first injection to capture the subsequently administered HA via in situ self-assembly on the cartilage surface, forming a natural cartilage-like lubrication layer. In vitro, this strategy reduced friction coefficients to normal cartilage levels in OA human cartilage. Moreover, sequential CS-g-PM and HA articular-injection in OA rats extended HA retention 5-fold versus HA alone; meanwhile, regeneration of cartilage was synergistically promoted. Importantly, a first-in-human pretrial demonstrated rapid MRI-evident cartilage repair at 1 month. At 6 months of follow-up, patients showed sustained functional improvement and halted structural degeneration. This strategy offers a transformative solution for OA treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.